Prevest Denpro Limited has fixed September 05, 2026, as the record date for the purpose of paying its final dividend on equity shares for Financial Year 2025-26. This determination was made by the Board of Directors and communicated to the Bombay Stock Exchange (BSE) on August 11, 2026. The actual disbursement of the dividend remains subject to its formal declaration at the company’s 27th Annual General Meeting (AGM).

The announcement serves to inform shareholders that only those holding equity shares in their demat accounts or physical folios as of the close of business on September 5, 2026, will be eligible to receive the final dividend, provided it is approved by shareholders at the AGM. This procedural step ensures clarity regarding entitlement timelines ahead of the general meeting.

Regulatory Compliance

The disclosure was made in accordance with Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations). Prevest Denpro Limited submitted the notice to the Corporate Relationship Department of BSE Limited, located at P.J. Towers, Dalal Street, Mumbai.

Key Details

Shareholder Implications

For investors, the record date is the critical cutoff for dividend eligibility. Shareholders who sell their holdings before September 5, 2026, will not be entitled to the final dividend for FY26, even if they held the shares during the financial year. Conversely, those who purchase shares on or before this date will qualify for the payout, assuming the dividend is declared at the 27th AGM.

The notice was signed by Pratul Gupta, Company Secretary & Compliance Officer of Prevest Denpro Limited, digitally dated August 11, 2026, at 17:23:10 +05'30'. The company has requested BSE to update its records accordingly to reflect this timeline for market participants.

Prevest Denpro reported a 12.9% increase in consolidated Profit After Tax (PAT) to ₹2,049.05 lakh for the financial year ended March 31, 2026, driven by robust revenue growth and operational efficiencies. The company’s Revenue from Operations rose by 13.9% to ₹7,180.85 lakh, while EBITDA increased by 13.3% to ₹2,962.11 lakh. On a standalone basis, the company achieved an EBITDA margin of 39.8%, an expansion of 80 basis points, underpinned by cost savings from import substitution and optimized capacity utilization at its 60,000 sq. ft. manufacturing facility.

Financial Performance

The strong top-line performance was complemented by margin expansion across profitability metrics. The Standalone PAT margin improved to 27.9%, up 80 basis points, while the Profit Before Tax (PBT) margin stood at 37.2%, an increase of 110 basis points. Sequential growth in the fourth quarter was particularly notable, with consolidated PBT growing by 21.2% and PAT by 23.3% over the third quarter, driven by strong year-end closures and effective leverage on fixed costs during peak volumes.

Consolidated Financials (FY 25-26 vs FY 24-25)

Operational Highlights

Prevest Denpro’s strategic focus on product innovation and global expansion yielded significant results during the year. The company rolled out the high-margin "Oradox" range and expanded its 3D printing resin portfolio. Import substitution of raw materials contributed to cost savings in procurement. Geographically, the company strengthened its presence through the establishment of Axiodent Inc. in the USA and Prevest Gulf LLC in the UAE, capitalizing on its footprint in over 90 countries.

Strategic Outlook

Looking ahead to FY27, Prevest Denpro plans to expand into new categories such as Digital Dentistry and Disinfectants to drive future growth. The company aims to strengthen its domestic presence in Tier I and Tier II markets while entering new international territories to increase exports. Continued investment in R&D and the development of indigenous raw materials are expected to support long-term competitiveness and sustainability.